Loading...
Zhengye Biotechnology Holding Limited
ZYBT•NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$10.31
$0.06(0.59%)
Zhengye Biotechnology Holding Limited (ZYBT) Stock Overview
Explore Zhengye Biotechnology Holding Limited’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for ZYBTStats details for ZYBT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ZYBTAnalyst Recommendations details for ZYBT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
CEO
Mr. Songlin Song
Employees
278
Headquarters
No.1 Lianmeng Road, Jilin
Founded
2025